Q1 EPS Estimates for Core Scientific Lowered by Roth Capital

Core Scientific, Inc. (NASDAQ:CORZ - Free Report) - Roth Capital dropped their Q1 2025 earnings per share estimates for Core Scientific in a note issued to investors on Wednesday, April 9th. Roth Capital analyst D. Aftahi now anticipates that the company will post earnings per share of ($0.14) for the quarter, down from their prior estimate of ($0.11). The consensus estimate for Core Scientific's current full-year earnings is $0.52 per share. Roth Capital also issued estimates for Core Scientific's Q2 2025 earnings at ($0.12) EPS, Q3 2025 earnings at ($0.12) EPS, Q4 2025 earnings at ($0.05) EPS, FY2025 earnings at ($0.43) EPS and Q1 2026 earnings at ($0.02) EPS.

Other analysts also recently issued reports about the stock. Canaccord Genuity Group restated a "buy" rating and set a $17.00 target price on shares of Core Scientific in a report on Wednesday, March 12th. Craig Hallum assumed coverage on shares of Core Scientific in a research report on Tuesday, January 21st. They issued a "buy" rating and a $24.00 price objective on the stock. Needham & Company LLC reduced their target price on shares of Core Scientific from $18.00 to $17.00 and set a "buy" rating for the company in a research note on Thursday, February 27th. Cantor Fitzgerald dropped their price target on Core Scientific from $24.00 to $21.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. Finally, Compass Point reduced their price objective on Core Scientific from $26.00 to $20.00 and set a "buy" rating for the company in a research report on Tuesday, February 25th. Fifteen analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $19.07.

Core Scientific Stock Performance

NASDAQ:CORZ traded up $0.04 on Monday, reaching $6.63. The company's stock had a trading volume of 9,748,300 shares, compared to its average volume of 12,485,531. The firm has a market cap of $1.96 billion, a PE ratio of -1.23 and a beta of 6.80. The business's 50-day moving average price is $8.81 and its two-hundred day moving average price is $12.54. Core Scientific has a 1-year low of $2.86 and a 1-year high of $18.63.

Core Scientific (NASDAQ:CORZ - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.10) by $0.09. The firm had revenue of $94.93 million for the quarter, compared to the consensus estimate of $97.07 million.

Institutional Investors Weigh In On Core Scientific

A number of large investors have recently added to or reduced their stakes in the business. Wellington Shields & Co. LLC bought a new position in shares of Core Scientific in the fourth quarter valued at about $26,000. First Horizon Advisors Inc. bought a new stake in shares of Core Scientific during the fourth quarter worth approximately $34,000. Newbridge Financial Services Group Inc. acquired a new position in shares of Core Scientific in the fourth quarter valued at approximately $42,000. GAMMA Investing LLC increased its stake in shares of Core Scientific by 1,722.3% during the first quarter. GAMMA Investing LLC now owns 8,565 shares of the company's stock worth $62,000 after purchasing an additional 8,095 shares during the period. Finally, Vestcor Inc acquired a new stake in Core Scientific during the 4th quarter worth approximately $66,000.

Insider Activity at Core Scientific

In other news, Director Jordan Levy bought 62,500 shares of the business's stock in a transaction that occurred on Thursday, March 6th. The stock was acquired at an average cost of $8.01 per share, for a total transaction of $500,625.00. Following the purchase, the director now owns 306,887 shares of the company's stock, valued at approximately $2,458,164.87. This trade represents a 25.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Todd M. Duchene sold 25,277 shares of the business's stock in a transaction that occurred on Friday, January 24th. The stock was sold at an average price of $16.24, for a total value of $410,498.48. Following the transaction, the insider now directly owns 2,023,423 shares in the company, valued at approximately $32,860,389.52. This trade represents a 1.23 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 530,041 shares of company stock valued at $7,870,352. 1.40% of the stock is owned by corporate insiders.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.